False
False
Recommended
False
Related Content
FDA Updates Potency Rules for Cell and Gene Therapies
November 11, 2026
2 min read
Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing
Lonza to Acquire Five US CDMO Sites from Merck KGaA
November 11, 2026
2 min read
The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network
BMS Details Patient Death in Zola-Cel Multiple Sclerosis Trial
November 3, 2026
2 min read
The company also reported early efficacy and safety data from the Phase I Breakfree-2 study
Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
November 2, 2026
2 min read
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited